Immune ablation and stem-cell therapy in autoimmune disease: Clinical experience
Open Access
- 1 January 2000
- journal article
- editorial
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 2 (4) , 276-280
- https://doi.org/10.1186/ar102
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Autologous Stem Cell Transplantation in Progressive Multiple Sclerosis—An Interim Analysis of EfficacyJournal of Clinical Immunology, 2000
- High-dose immunosuppressive therapy for rheumatoid arthritis: Some answers, more questionsArthritis & Rheumatism, 1999
- Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritisArthritis & Rheumatism, 1999
- Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortalityBone Marrow Transplantation, 1999
- Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.1998
- Stem cell transplantation for severe autoimmune diseases: progress and problems.1998
- Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)Rheumatology, 1997
- HTLV screening of Swedish blood donorsThe Lancet, 1995
- Techniques for autologous transplantsThe Lancet, 1995
- BMT in experimental autoimmune diseases.1993